Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artiva Biotherapeutics (ARTV) Minority Interest (2023 - 2024)

Artiva Biotherapeutics (ARTV) has disclosed Minority Interest for 2 consecutive years, with $96.8 million as the latest value for Q2 2024.

  • For Q2 2024, Minority Interest changed N/A year-over-year to $96.8 million; the TTM value through Jun 2024 reached $96.8 million, changed N/A, while the annual FY2023 figure was $96.8 million, N/A changed from the prior year.
  • Minority Interest hit $96.8 million in Q2 2024 for Artiva Biotherapeutics, roughly flat from $96.8 million in the prior quarter.
  • Across five years, Minority Interest topped out at $96.8 million in Q4 2023 and bottomed at $96.8 million in Q4 2023.